Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin. (Q36618801)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 1999

edit

Language	Label	Description	Also known as
English	Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.	scientific article published on February 1999

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

title

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

main subject

pharmacokinetics

1 reference

based on heuristic

inferred from title

author

Elisabeth de Vries

series ordinal

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

author name string

de Jong RS

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

Mulder NH

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

Uges DR

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

Sleijfer DT

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

Höppener FJ

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

Groen HJ

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

Willemse PH

series ordinal

7

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

van der Graaf WT

series ordinal

8

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

published in

British Journal of Cancer

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

volume

79

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

issue

5-6

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

page(s)

882-887

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

cites work

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

retrieved

30 September 2017

DNA topoisomerase I and II as targets for rational design of new anticancer drugs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

retrieved

30 September 2017

Chromosome condensation induced by fostriecin does not require p34cdc2 kinase activity and histone H1 hyperphosphorylation, but is associated with enhanced histone H2A and H3 phosphorylation.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

retrieved

30 September 2017

Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

retrieved

30 September 2017

Preclinical toxicological evaluation of fostriecin, a novel anticancer antibiotic, in rats

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

retrieved

30 September 2017

Mechanisms of resistance to drugs that inhibit DNA topoisomerases

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

retrieved

30 September 2017

Catalytic function of DNA topoisomerase II.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

retrieved

30 September 2017

Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

retrieved

28 June 2018

Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

retrieved

28 June 2018

MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

retrieved

28 June 2018

Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10070885

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal toxicity of the anticancer drug fostriecin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10070885

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of the novel antitumor antibiotic fostriecin (CI-920) in a human tumor cloning assay

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10070885

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of type II topoisomerase by fostriecin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10070885

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of fostriecin pharmacokinetics in plasma using high-pressure liquid chromatography assay

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10070885

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10070885

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10070885

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/SJ.BJC.6690141

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

PMC publication ID

2362650

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

PubMed publication ID

10070885

1 reference

stated in

Europe PubMed Central

PMC publication ID

2362650

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

ResearchGate publication ID

13219727

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36618801&oldid=2199100584"